This article discusses a recent study on the immune responses to COVID-19 vaccination among patients with rheumatoid arthritis. The study found that patients on immunosuppressive therapies may have weaker immune responses to the vaccine, which could lead to more severe disease outcomes. The us...
The purpose of this study was to assess whether rheumatoid arthritis (RA) patients who received the mRNA COVID-19 vaccine are at increased risk for disease flare. Methods We conducted a single-center retrospective and prospective study at the Louis Stokes Cleveland VA Medical Center between 12/20...
Rheumatoid arthritis is a chronic autoimmune inflammatory disease affecting joints and more. Reviewed by a board-certified rheumatologist.
This study aimed to conduct a comprehensive systematic literature review and meta-analysis to assess the risk and outcomes of coronavirus disease 2019 (COVID-19) in patients with rheumatoid arthritis. A systematic search was performed across four electro
University of Leeds-led research has identified specific changes in the gut microbiome of individuals at risk of rheumatoid arthritis, potentially discovering disease onset mechanisms. Nov 11, 2024report 0 89 Diseases, Conditions, Syndromes COVID-19 linked to long-term risk for autoimmune, autoinflamma...
26, 2021 (HealthDay News) -- Rheumatoid arthritis drugs may save lives of patients hospitalized with severe cases of COVID-19, according to a groundbreaking clinical trial.The findings, first announced in January, have now been peer-reviewed and published in a major medical journal. ...
I have rheumatoid arthritis and would like to know what the risks are involved if I were to get sick with the coronavirus (COVID-19). Am I more likely to get COVID-19 if I have rheumatoid arthritis? What can I expect?
Find medically reviewed information on rheumatoid arthritis covering symptoms, diagnosis, tests, treatment, and more.
Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic joint inflammation. Learn about causes, symptoms, stages, treatments, medications, prognosis, complications, and prevention.
A drug against rheumatoid arthritis called baricitinib could potentially be repurposed to treat patients with COVID-19, according to a study conducted by an international research team including researchers at Karolinska Institutet in Sweden. The finding